Ad is loading...
MENU

KALV KalVista Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of pharmaceuticals

Industry Biotechnology
KALV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
KALV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KALV is expected to report earnings to rise 6.56% to -92 cents per share on December 05

KalVista Pharmaceuticals KALV Stock Earnings Reports
Q4'24
Est.
$-0.93
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.31
Q1'24
Missed
by $0.09
Q4'23
Missed
by $0.04
The last earnings report on September 05 showed earnings per share of -87 cents, beating the estimate of -89 cents. With 816.27K shares outstanding, the current market capitalization sits at 467.05M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
55 Cambridge Parkway
Phone
+1 857 999-0075
Employees
118
Web
https://www.kalvista.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EQNUX22.48-0.15
-0.66%
MFS Equity Income R4
MITCX37.33-0.46
-1.22%
MFS Massachusetts Investors Tr C
RTSSX43.28-0.59
-1.34%
Russell Inv Tax-Managed US Mid&Sm Cap S
SPFFX27.01-0.39
-1.42%
Sphere 500 Climate Fund
BSGIX17.19-0.27
-1.55%
Baird Small/Mid Cap Growth Institutional

KALV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KALV has been loosely correlated with FATE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if KALV jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALV
1D Price
Change %
KALV100%
-3.16%
FATE - KALV
45%
Loosely correlated
-2.88%
INZY - KALV
44%
Loosely correlated
-8.89%
PLRX - KALV
42%
Loosely correlated
-3.27%
ALLO - KALV
41%
Loosely correlated
-7.72%
IDYA - KALV
41%
Loosely correlated
-9.60%
More